These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25942477)

  • 1. Elevated Lipoprotein Lipase Activity Does Not Account for the Association Between Adiponectin and HDL in Type 1 Diabetes.
    Calderon RM; Diaz S; Szeto A; Llinas JA; Hughes TA; Mendez AJ; Goldberg RB
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2581-8. PubMed ID: 25942477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
    De Vries R; Wolffenbuttel BH; Sluiter WJ; van Tol A; Dullaart RP
    Clin Lab; 2005; 51(7-8):403-9. PubMed ID: 16122151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance.
    von Eynatten M; Schneider JG; Humpert PM; Rudofsky G; Schmidt N; Barosch P; Hamann A; Morcos M; Kreuzer J; Bierhaus A; Nawroth PP; Dugi KA
    Diabetes Care; 2004 Dec; 27(12):2925-9. PubMed ID: 15562208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein composition in patients with type 1 diabetes mellitus: Impact of lipases and adipokines.
    Hughes TA; Calderon RM; Diaz S; Mendez AJ; Goldberg RB
    J Diabetes Complications; 2016; 30(4):657-68. PubMed ID: 26997169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.
    Shirakawa T; Nakajima K; Shimomura Y; Kobayashi J; Stanhope K; Havel P; Machida T; Sumino H; Murakami M
    Clin Chim Acta; 2015 Feb; 440():193-200. PubMed ID: 25239670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia.
    Kuusi T; Ehnholm C; Viikari J; Härkönen R; Vartiainen E; Puska P; Taskinen MR
    J Lipid Res; 1989 Aug; 30(8):1117-26. PubMed ID: 2504859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase genotypes, lipoprotein lipase activity, and HDL.
    Nevin DN; Zambon A; Furlong CE; Richter RJ; Humbert R; Hokanson JE; Brunzell JD
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1243-9. PubMed ID: 8857920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II.
    Kawaguchi A; Miyao Y; Noguchi T; Nonogi H; Yamagishi M; Miyatake K; Kamikubo Y; Kumeda K; Tsushima M; Yamamoto A; Kato H
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):251-8. PubMed ID: 10634826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.
    Frénais R; Nazih H; Ouguerram K; Maugeais C; Zaïr Y; Bard JM; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 May; 86(5):1962-7. PubMed ID: 11344192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-heparin lipoprotein lipase mass as a potential mediator in the association between adiponectin and HDL-cholesterol in type 2 diabetes.
    Maser RE; Lenhard MJ; Pohlig RT; Balagopal PB
    J Clin Transl Endocrinol; 2017 Mar; 7():7-11. PubMed ID: 29067244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome.
    Shirakawa T; Nakajima K; Yatsuzuka S; Shimomura Y; Kobayashi J; Machida T; Sumino H; Murakami M
    Clin Chim Acta; 2015 Feb; 440():123-32. PubMed ID: 25445417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
    Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
    Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels.
    Cominacini L; Garbin U; Davoli A; Campagnola M; De Santis A; Pasini C; Pastorino AM; Bosello O
    Ann Nutr Metab; 1993; 37(4):175-84. PubMed ID: 8215234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males.
    Sorva R; Kuusi T; Taskinen MR; Perheentupa J; Nikkilä EA
    Atherosclerosis; 1988 Feb; 69(2-3):191-7. PubMed ID: 3126749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the serum lipoprotein lipase concentration is useful for studying triglyceride metabolism: Comparison with postheparin plasma.
    Hirano T; Nishioka F; Murakami T
    Metabolism; 2004 Apr; 53(4):526-31. PubMed ID: 15045703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease.
    Tornvall P; Karpe F; Proudler A; Båvenholm P; Landou C; Olivecrona T; Hamsten A
    Metabolism; 1996 Nov; 45(11):1375-82. PubMed ID: 8931642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipoproteins and lipolytic enzyme activities during endurance training in sedentary men: changes in high-density lipoprotein subfractions and composition.
    Stubbe I; Hansson P; Gustafson A; Nilsson-Ehle P
    Metabolism; 1983 Dec; 32(12):1120-8. PubMed ID: 6417447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.
    Tani M; Horvath KV; Lamarche B; Couture P; Burnett JR; Schaefer EJ; Asztalos BF
    Atherosclerosis; 2016 Oct; 253():7-14. PubMed ID: 27573733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity.
    Kahri J; Vuorinen-Markkola H; Tilly-Kiesi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1993 Aug; 102(1):79-89. PubMed ID: 8257455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of lipoprotein lipase increases serum high density lipoprotein 2 cholesterol and enlarges high density lipoprotein 2 particles in rats.
    Kusunoki M; Tsutsumi K; Sato D; Nakamura A; Habu S; Mori Y; Morishita M; Yonemoto T; Miyata T; Nakaya Y; Nakamura T
    Eur J Pharmacol; 2011 Oct; 668(1-2):337-9. PubMed ID: 21756896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.